Anterix Inc. Files 8-K on Shareholder Vote Matters

Ticker: ATEX · Form: 8-K · Filed: Aug 7, 2025 · CIK: 1304492

Sentiment: neutral

Topics: 8-K, governance, shareholder-vote

TL;DR

Anterix filed an 8-K on Aug 7th about a shareholder vote on Aug 5th. Standard governance stuff.

AI Summary

Anterix Inc. filed an 8-K on August 7, 2025, reporting on matters submitted to a vote of security holders on August 5, 2025. The filing details the company's corporate actions and governance, as is standard for this type of report.

Why It Matters

This filing provides transparency into Anterix Inc.'s corporate governance and decisions made by its security holders, which can impact shareholder rights and company direction.

Risk Assessment

Risk Level: low — This is a routine 8-K filing regarding a vote of security holders, which typically does not involve new financial risks or significant operational changes.

Key Players & Entities

FAQ

What specific matters were submitted to a vote of Anterix Inc.'s security holders on August 5, 2025?

The filing indicates that matters were submitted to a vote of security holders on August 5, 2025, but the specific details of these matters are not provided in the excerpt.

When did Anterix Inc. file this Current Report on Form 8-K?

Anterix Inc. filed this Current Report on Form 8-K on August 7, 2025.

What is the principal executive office address for Anterix Inc.?

The principal executive office address for Anterix Inc. is 3 Garret Mountain Plaza, Suite 401, Woodland Park, NJ 07424.

What is Anterix Inc.'s SEC File Number?

Anterix Inc.'s SEC File Number is 001-36827.

What is the IRS Employer Identification Number for Anterix Inc.?

The IRS Employer Identification Number for Anterix Inc. is 33-0745043.

Filing Stats: 818 words · 3 min read · ~3 pages · Grade level 10.1 · Accepted 2025-08-07 16:21:08

Key Financial Figures

Filing Documents

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. On August 5, 2025, Anterix Inc. (the " Company ") held its 2025 Annual Meeting of Stockholders (the " Annual Meeting ") virtually commencing at 9:30 a.m. Eastern Time. Of the 18,693,957 shares of the Company's common stock (the " Common Stock ") issued and outstanding and eligible to vote as the record date on June 12, 2025, a quorum of 15,788,588 shares of Common Stock, or approximately 84.45% of the eligible shares of Common Stock, were represented at the Annual Meeting either in person or by proxy. A description of each matter voted upon at the Annual Meeting is set forth in the Company's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on June 30, 2025 (the " Proxy Statement "). The following actions were taken at the Annual Meeting: (1) Election of Directors . The Company's stockholders elected Jeffrey A. Altman, Leslie B. Daniels, Mark A. Fleischhauer, Thomas R. Kuhn, William E. Heard, Scott A. Lang and Mahvash Yazdi as directors, to hold office until the 2026 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified. Each director nominee received more "FOR" votes than "AGAINST" votes, and more than a majority of the votes cast. The following table shows the number of votes cast "FOR" or "AGAINST" and the number of "ABSTENTIONS" and "BROKER NON-VOTES" for each nominee: Director For Against Abstentions Broker Non-Votes Jeffrey A. Altman 13,994,163 569,141 5188 1,220,096 Leslie B. Daniels 12,522,243 2,040,961 5,288 1,220,096 Mark A. Fleischhauer 14,388,878 173,546 6,068 1,220,096 William E. Heard 14,355,956 207,248 5,288 1,220,096 Thomas R. Kuhn 14,314,261 249,043 5,188 1,220,096 Scott A. Lang 14,351,947 211,357 5,188 1,220,096 Mahvash Yazdi 13,742,487 818,017 7,988 1,220,096 (2) Advisory Vote on the Compensation of the Named Executive Officers . The Company's stockholders approved, on a non-bindin

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 104 Cover Page Interactive Data File (formatted as Inline XBRL).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Anterix Inc. Date: August 7, 2025 /s/ Gena L. Ashe Gena L. Ashe Chief Legal Officer and Corporate Secretary

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing